Skip to content

Osteofil, Optefil, Regenafil, Rti Allograft Paste

by Regeneration Technologies, Inc.

510(k) K043420

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

13 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK043420 Date10 Feb 2005ClearedStatusActive

Recalls

13 recalls · FDA

    • Terminated Z-2634-2011 FDA Unclassified (pre-2012) initiated 9 Apr 2011

    RTI Biologics issued a recall of Osteofil DBM Paste, 5cc that was distributed on 03/04/2008 to one customer. The product was labeled as 5.0cc but should have been labeled as 0.5cc. All customers were notified of this recall on 04/09/2011.

  • 12 recalls, same reason

    • Terminated Z-0487-06 FDA Unclassified (pre-2012) initiated 14 Oct 2005
    • Terminated Z-0492-06 FDA Unclassified (pre-2012) initiated 14 Oct 2005
    • Terminated Z-0497-06 FDA Unclassified (pre-2012) initiated 14 Oct 2005
    • Terminated Z-0490-06 FDA Unclassified (pre-2012) initiated 14 Oct 2005
    • Terminated Z-0500-06 FDA Unclassified (pre-2012) initiated 14 Oct 2005
    • Terminated Z-0499-06 FDA Unclassified (pre-2012) initiated 14 Oct 2005
    • Terminated Z-0494-06 FDA Unclassified (pre-2012) initiated 14 Oct 2005
    • Terminated Z-0481-06 FDA Unclassified (pre-2012) initiated 14 Oct 2005
    • Terminated Z-0493-06 FDA Unclassified (pre-2012) initiated 14 Oct 2005
    • Terminated Z-0498-06 FDA Unclassified (pre-2012) initiated 14 Oct 2005
    • Terminated Z-0491-06 FDA Unclassified (pre-2012) initiated 14 Oct 2005
    • Terminated Z-0496-06 FDA Unclassified (pre-2012) initiated 14 Oct 2005

    The tissue was collected from donors for whom there is no verifiable identity or consent. The medical records and social histories of the donors cannot be ascertained. The devices which incorporate these donor bone tissues undergo processing, including sterilization, which has been validated to inactivate and/or remove all viral diseases for which human tissue donors are tested.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MQV
Device Class
Class II
Regulation
21 CFR Part 888.3045
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Other devices from Regeneration Technologies, Inc.

See all devices from Regeneration Technologies, Inc. →